Skip to main content


Figure 3 | BMC Research Notes

Figure 3

From: Bupropion, methylphenidate, and 3,4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence

Figure 3

The potencies of the drugs (log IC 50 values) to inhibit DA uptake correlate linearly with their potencies to inhibit methamphetamine-induced DA release (correlation coefficient > 0.99, p < 0.05, regression line and 95% confidence intervals).

Back to article page